Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
The SP 500 index level can hint at breadth and momentum, helping you gauge whether moves are broad-based or narrow.
23,589 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
AI investing often spotlights flashy chips, but the real winners are the enablers. Rambus sits at the nexus of securi...
As July rolls in, space stocks attract attention—but not all rockets rise equally. This guide spotlights two practica...
Pentair faced a sharp drop as investors weighed leadership changes, lower guidance, and new scrutiny. This in-depth l...
Marvell faces a pivotal year as data centers, 5G networks, and AI workloads shape demand. This guide breaks down what...
A big bet on a digital banking stock can signal confidence in transformation, but a 30% drop demands careful scrutiny...
Energy Transfer sits at the heart of U.S. energy infrastructure. This guide explains when energy transfer stock right...
A major fund just walked away from its Li Auto position, selling roughly $33 million worth of shares in one quarter. ...
Arm Holdings sparked a rally as investors eyed its AI push and the Arm Everywhere event. This article breaks down why...
Energy Holdings disclosed a large stake in Tecnoglass, prompting questions about what tecnoglass stock after energy s...
A synthetic contract puts SpaceX at a $2.4 trillion implied IPO, a figure that dwarfs Facebook's listing and tests ho...
Vanguard’s 8-for-1 split lowered VGT’s price, letting smaller investors pursue income strategies through covered call...